|
Volumn 21, Issue 6, 2001, Pages 599-602
|
The H1-receptor antagonist dextro-chlorpheniramine impairs selective auditory attention in the absence of subjective awareness of this impairment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DEXCHLORPHENIRAMINE;
HISTAMINE H1 RECEPTOR ANTAGONIST;
CHLORPHENIRAMINE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG SAFETY;
EVENT RELATED POTENTIAL;
HEARING ACUITY;
HEARING IMPAIRMENT;
HUMAN;
HUMAN EXPERIMENT;
MALE;
NORMAL HUMAN;
PRIORITY JOURNAL;
SELECTIVE ATTENTION;
SOMNOLENCE;
TASK PERFORMANCE;
ANALYSIS OF VARIANCE;
ATTENTION;
AWARENESS;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG SCREENING;
EVOKED AUDITORY RESPONSE;
METHODOLOGY;
PHYSIOLOGY;
ADULT;
ANALYSIS OF VARIANCE;
ATTENTION;
AWARENESS;
CHLORPHENIRAMINE;
DOUBLE-BLIND METHOD;
DRUG EVALUATION;
EVOKED POTENTIALS, AUDITORY;
HISTAMINE H1 ANTAGONISTS;
HUMAN;
MALE;
SUPPORT, NON-U.S. GOV'T;
|
EID: 0034747296
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/00004714-200112000-00010 Document Type: Article |
Times cited : (6)
|
References (25)
|